Drug Shortage Report for ODAN-NAPHAZOLINE
Report ID | 1022 |
Drug Identification Number | 00626570 |
Brand name | ODAN-NAPHAZOLINE |
Common or Proper name | Naphazoline Hydrochloride Ophthalmic Solution, USP |
Company Name | ODAN LABORATORIES LTD |
Market Status | DORMANT |
Active Ingredient(s) | NAPHAZOLINE HYDROCHLORIDE |
Strength(s) | .1% |
Dosage form(s) | SOLUTION |
Route of administration | OPHTHALMIC |
Packaging size | 15 mL |
ATC code | S01GA |
ATC description | DECONGESTANTS AND ANTIALLERGICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2016-04-15 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2017-10-05 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | info@odanlab.com Tel.: 1-800-387-9342 Fax: 1-800-329-6326 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2017-03-13 | French | Compare |
v3 | 2017-03-13 | English | Compare |
v2 | 2017-03-13 | French | Compare |
v1 | 2017-03-13 | English | Compare |
Showing 1 to 4 of 4